Related references
Note: Only part of the references are listed.Interleukin-18 Has Antipermeablity and Antiangiogenic Activities in the Eye: Reciprocal Suppression With VEGF
Jikui Shen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
IL-18 Attenuates Experimental Choroidal Neovascularization as a Potential Therapy for Wet Age-Related Macular Degeneration
Sarah L. Doyle et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
DICER1 Loss and Alu RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88
Valeria Tarallo et al.
CELL (2012)
NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components
Sarah L. Doyle et al.
NATURE MEDICINE (2012)
A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancer
Michael J. Robertson et al.
CLINICAL CANCER RESEARCH (2008)
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Mark E. Kleinman et al.
NATURE (2008)
Interleukin-18 regulates pathological intraocular neovascularization
Hong Qiao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer
Michael J. Robertson et al.
CLINICAL CANCER RESEARCH (2006)
Abnormal retinal vascular development in IL-18 knockout mice
H Qiao et al.
LABORATORY INVESTIGATION (2004)
Share Paper
